Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16293-16299
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
Table 1 Descriptive details and diagnoses of the ROME III and ROME II cohorts1
Table 2 Prevalence of functional gastrointestinal disorders categories for ROME III (with and without 6-mo requirement) and ROME II (with 3-mo requirement)
ROME III cohort (n = 100) | ROME II cohort (n = 160) | ||
With 6-mo requirement | With 3-mo requirement | Present 3 mo or more | |
Region | |||
A: Functional Esophageal Disorders | 34% | 55% | 40% |
B: Functional Gastroduodenal Disorders | 62% | 79% | 16% |
Without cyclic vomiting | 45% | 60% | |
C: Functional Bowel Disorders | 77% | 98% | 88% |
Without unspecified bowel disease | 53% | 80% | |
D: Functional Abdominal Pain Syndrome | 3% | 6% | 4% |
E: Functional Gallbladder and Sphincter of Oddi Disorders | 0% | 2% | |
F: Functional Anorectal Disorders1 | 16% | 20% | 35% |
Total | |||
At least one FGID | 83% | 94% | |
At least 3 FGIDs | 34% | 36% |
Table 3 Prevalence of individual functional gastrointestinal disorders present in ROME III with and without 6-mo presence requirement and the prevalence of these in ROME II
ROME III (n = 100) | ROME II (n = 160) | ||
With 6-mo requirement | With 3-mo requirement | Present 3 mo or more | |
A1: Functional Heartburn1 | 22% | 26% | 24% |
A2: Functional Chest Pain of Presumed Esophageal Origin1 | 8% | 17% | 4% |
A3: Functional Dysphagia1 | 6% | 16% | 9% |
A4: Globus1 | 1% | 2% | 5% |
B1: Functional Dyspepsia1 | 0% | 57% | 7% |
B1a: Postprandial Distress Syndrome1 | 45% | 72% | - |
B2a: Aerophagia1 | 14% (a,b combined) | 18% (a,b combined) | 11% |
B2b: Unspecified Excessive Belching1 | - | ||
B3a: Chronic idiopathic nausea1 | 10% | 14% | - |
B3c: Cyclic vomiting syndrome | 17% | 19% | - |
B4: Rumination Syndrome in Adults1 | 7% | 7% | 2% |
C1: Irritable Bowel Syndrome1 | 41% | 57% | 45% |
C2: Functional Bloating1 | 1% | 3% | 30% |
C3: Functional Constipation1 | 11% | 27% | 26% |
C5: Unspecified Functional Bowel Disorder1 | 24% | 18% | - |
F1: Functional Fecal Incontinence (3 mo) | 15% | 15% | 11% |
F2a: Chronic Proctalgia1 | 5% | 5% | - |
F2b: Proctalgia Fugax (3 mo) | 11% | 11% | 21% |
Table 4 Prevalence of functional gastrointestinal disorders categories for ROME III (with 6-mo requirement) by eating disorder sub-types
ROME III cohort | |||||
AN-R (n = 27) | AN-P (n = 20) | BN (n = 9) | EDNOS-R (n = 14) | EDNOS-P (n = 30) | |
A: Functional Esophageal Disorders | 14.8% | 35.0% | 33.3% | 42.9% | 46.7% |
B: Functional Gastroduodenal Disorders | 44.4% | 75.0% | 88.9% | 42.9% | 70.0% |
Without cyclic vomiting | 44.4% | 60.0% | 44.4% | 35.7% | 40.0% |
C: Functional Bowel Disorders | 63.0% | 85.0% | 77.8% | 85.7% | 80.0% |
Without unspecified bowel disease | 40.7% | 65.0% | 55.6% | 50.0% | 56.7% |
D: Functional Abdominal Pain Syndrome | 7.4% | 5.0% | 0.0% | 0.0% | 0.0% |
E: Functional Anorectal Disorders1 | 7.4% | 10.0% | 11.1% | 35.7% | 20.0% |
Total | |||||
At least one FGID | 70.4% | 95.0% | 88.9% | 85.7% | 83.3% |
At least 3 FGIDs | 18.5% | 40.0% | 33.3% | 35.7% | 43.3% |
Table 5 Behavioural and psychological predictors of the commonly occurring ROME III functional gastrointestinal disorders among eating disorder patients
ROME III FGID | Predictors | B | Wald | υ | P | OR | 95%CI | |
A1: Functional Heartburn | Somatisation | 0.13 | 5.31 | 1 | 0.021 | 1.14 | 1.02 | 1.27 |
B1a: Postprandial Distress Syndrome | Starvation | 0.58 | 6.99 | 1 | 0.008 | 1.79 | 1.16 | 2.76 |
Exercise | -0.57 | 6.23 | 1 | 0.013 | 0.56 | 0.36 | 0.88 | |
Depression | 0.67 | 4.73 | 1 | 0.030 | 1.07 | 1.01 | 1.14 | |
C1: Irritable Bowel Syndrome | Laxatives | 0.46 | 5.05 | 1 | 0.025 | 1.58 | 1.06 | 2.35 |
C5: Unspecified Functional Bowel Disorder | Somatisation | -0.19 | 7.21 | 1 | 0.007 | 0.83 | 0.73 | 0.95 |
- Citation: Wang X, Luscombe GM, Boyd C, Kellow J, Abraham S. Functional gastrointestinal disorders in eating disorder patients: Altered distribution and predictors using ROME III compared to ROME II criteria. World J Gastroenterol 2014; 20(43): 16293-16299
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16293.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16293